We existed in our own world that day, absorbing information we never wanted to learn. At one point, while I was crying ...
A Muskego family helped raise more than $5.5 million to fund early access treatment for children with Sanfilippo syndrome ...
The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...
By identifying the causes of a rare condition known as auto-brewery syndrome (ABS), scientists can perfect methods for ...
The U.S. Food and Drug Administration has extended its review for the expanded ​use of Travere Therapeutics’ drug to treat a ...
Biogen CEO Chris Viehbacher joins 'Squawk Box' to discuss the company's 2026 outlook, drug pipeline, the focus on rare ...
The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...
Full pipelines and rising revenues lead rare disease biotechs to restyle themselves as more mature, global biopharma ...
ANI Pharmaceuticals (NASDAQ:ANIP) outlined plans to accelerate its shift toward rare disease medicines while maintaining profitability and cash generation from its generics business, according to ...
The FDA previously rejected Zycubo for Menkes disease in October last year, citing issues with the drug’s manufacturing ...
FDA approves 1st treatment for Menkes disease, offering a copper therapy that improves survival in affected children.
As someone living with a rare disease in Ohio, I know how fragile access to life-saving treatment can be. A bill to help patients with rare or life-threatening illnesses is currently being debated in ...